[HTML][HTML] Effectiveness of direct oral anticoagulants in obese adults with atrial fibrillation: a systematic review of systematic reviews and meta-analysis
Background: Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmia.
Obesity is an independent risk factor for AF. Anticoagulants have been strongly …
Obesity is an independent risk factor for AF. Anticoagulants have been strongly …
Efficacy and safety of direct oral anticoagulant in morbidly obese patients with atrial fibrillation: systematic review and meta-analysis
S Thangjui, J Kewcharoen, R Yodsuwan… - European Heart …, 2022 - academic.oup.com
Aims We conducted a systematic review and meta-analysis on three outcomes. We
assessed the efficacy and safety of direct oral anticoagulants (DOAC) compared to vitamin K …
assessed the efficacy and safety of direct oral anticoagulants (DOAC) compared to vitamin K …
Direct oral anticoagulants versus warfarin in morbidly obese patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis
Background: Direct oral anticoagulants (DOACs) have been increasingly preferred over
warfarin; however, The International Society of Thrombosis and Hemostasis recommended …
warfarin; however, The International Society of Thrombosis and Hemostasis recommended …
Meta-analysis comparing direct oral anticoagulants versus warfarin in morbidly obese patients with atrial fibrillation
K Kido, M Shimizu, T Shiga, M Hashiguchi - The American journal of …, 2020 - Elsevier
Highlights•Direct oral anticoagulants did not increase stroke or systemic embolism event
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation across BMI categories: a systematic review and meta-analysis
Objectives Concerns have arisen recently over the relationship between body mass index
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …
Direct-acting oral anticoagulant choice for stroke prevention in obese patients with atrial fibrillation
T Brar, D Chua - Canadian Journal of Cardiology, 2021 - Elsevier
Anticoagulation with direct-acting oral anticoagulants (DOACs) is recommended over
warfarin for stroke prevention in patients with atrial fibrillation (AF). The efficacy of DOACs …
warfarin for stroke prevention in patients with atrial fibrillation (AF). The efficacy of DOACs …
Comparative effectiveness and safety of direct oral anticoagulants in obese patients with atrial fibrillation
Background Unlike warfarin direct oral anticoagulants (DOACs) are administered in fixed
doses, which raises concerns of its effectiveness on larger patients. Data from randomized …
doses, which raises concerns of its effectiveness on larger patients. Data from randomized …
Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis
Aims This study sought to determine the impact of weight and body mass index (BMI) on the
safety and efficacy of direct-acting oral anticoagulants (DOACs) compared with warfarin in …
safety and efficacy of direct-acting oral anticoagulants (DOACs) compared with warfarin in …
[HTML][HTML] Comparative effectiveness and safety of direct oral anticoagulants vs warfarin among obese patients with atrial fibrillation
Background Obese patients are underrepresented in clinical trials assessing the
comparative effectiveness and safety of use of direct oral anticoagulants vs use in atrial …
comparative effectiveness and safety of use of direct oral anticoagulants vs use in atrial …
Effectiveness and safety of direct oral anticoagulants for stroke prevention in atrial fibrillation patients with extreme obesity
B Elad, N Maman, S Ayalon, LH Goldstein - The American Journal of …, 2023 - Elsevier
Direct oral anticoagulants (DOACs) are a favored treatment to prevent stroke in patients with
atrial fibrillation (AF). There are limited data concerning the efficacy and safety of DOACs in …
atrial fibrillation (AF). There are limited data concerning the efficacy and safety of DOACs in …